Updated March 1, 2024
Go to JCI Insight's conflict-of-interest policy
Allocyte (D.A. Fox)
Almirall (J.E. Gudjonsson)
Arcus Biosciences (Y.M. Shah)
Arvinas (A.P. Lieberman)
Boehringer Ingelheim (J.E. Gudjonsson)
Chugai Pharmaceutical Co. (N. Kamada)
CStone Pharmaceuticals (W. Zou)
Eli Lilly (D.M. Martin)
Galderma (J.E. Gudjonsson)
HanchorBio (W. Zou)
Janssen (J.E. Gudjonsson)
Johnson & ohnson (D.M. Martin)
Medtronic (D.M. Martin)
Merck (D.M. Martin)
Miyarisan (N. Kamada)
NGM Bio (W. Zou)
ONL Therapeutics (A.W. Tai)
Opsidio LLC (N.W. Lukacs)
Procter & Gamble (D.M. Martin)
Prometheus (J.E. Gudjonsson)
Roivant (W. Zou)
UnitedHealth Group (D.M. Martin)